Encompass Health Corporation (EHC)

NYSE: EHC · Real-Time Price · USD

141.03

+6.24 (4.63%)

At close: Nov 4, 2026, 4:00 PM EST

141.05

+0.02 (0.01%)

Pre-market: Nov 5, 2026, 4:48 AM EST

Encompass Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	644.4	566.2	455.7	352	271	412.2
Depreciation & Amortization	359.8	327.9	299.6	273.9	243.6	219.6
Other Amortization	9.6	9.6	9.7	9.5	9.7	7.8
Loss (Gain) From Sale of Investments	-15.7	-	-	-	-	-
Loss (Gain) on Equity Investments	-0.2	-0.2	1	-1.6	1.1	-0.8
Stock-Based Compensation	58.7	56.5	48.3	50.6	29.2	29.1
Other Operating Activities	225.7	212.7	169.7	132.1	129.3	6.7
Change in Accounts Receivable	-85.9	-15.2	3	-22.4	-16.9	-39.5
Change in Accounts Payable	53.6	-22.6	3	11.8	2.3	15.6
Change in Other Net Operating Assets	33.4	42.1	15.9	60.9	-15.8	-86
Operating Cash Flow	1,304	1,176	1,003	850.8	705.8	715.8
Operating Cash Flow Growth	17.62%	17.23%	17.87%	20.54%	-1.40%	1.57%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-846.5	-736.4	-642.5	-583.1	-584.1	-545.7
Other Investing Activities	-20.2	-28.2	-10.8	-19.7	-42.9	-120.6
Investing Cash Flow	-866.7	-764.6	-653.3	-602.8	-627	-666.3

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	-	210	95	80	251.8	300
Long-Term Debt Repaid	-	-239	-337	-163.3	-750	-359.1
Net Debt Issued (Repaid)	151.5	-29	-242	-83.3	-498.2	-59.1
Repurchase of Common Stock	-311	-178	-43.2	-8.2	-7.3	-14.6
Common Dividends Paid	-76.9	-71.1	-62.8	-60.4	-99	-112.2
Other Financing Activities	-194.1	-153.1	17.4	-45.3	458.8	-54.2
Financing Cash Flow	-430.5	-431.2	-330.6	-197.2	-145.7	-240.1

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	6.5	-20.2	18.9	50.8	-66.9	-190.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	457.2	439.2	360.3	267.7	121.7	170.1
Free Cash Flow Growth	13.56%	21.90%	34.59%	119.97%	-28.45%	-45.46%
Free Cash Flow Margin	7.21%	7.40%	6.71%	5.58%	2.80%	4.24%
Free Cash Flow Per Share	4.54	4.30	3.52	2.64	1.21	1.70
Levered Free Cash Flow	266.9	296.79	215.84	123.69	-3.34	-73.86
Unlevered Free Cash Flow	336.68	364.19	292.01	203.88	96.78	21.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash Interest Paid	133.1	133.1	146.8	147.7	178.4	-
Cash Income Tax Paid	-	-	163.8	106.6	50.2	129.6
Change in Working Capital	1.1	4.3	21.9	50.3	-30.4	-109.9

SEC Filings: 10-K · 10-Q